Moderna

Moderna ties up with Immatics to boost cancer vaccine development
World+Biz

Moderna ties up with Immatics to boost cancer vaccine development

Moderna said the companies would use Immatics' drug discovery platform to develop mRNA-based cancer vaccines, and also study its own cancer vaccine for use in combination with Immatics'...

FILE PHOTO: A vial and sryinge are seen in front of a displayed Moderna logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
World+Biz

Moderna says updated Covid vaccine is effective against newer variant

FILE PHOTO: A Ugandan health worker prepares to administer the ebola vaccine to a man in Kirembo village, near the border with the Democratic Republic of Congo in Kasese district, Uganda, June 16, 2019. REUTERS/James Akena/
Health

Cancer and heart disease vaccines expected to be ready by 2030

Photo: Collected
World+Biz

Moderna reports positive results for RSV vaccine

A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
World+Biz

Moderna refused China request to reveal vaccine technology: Financial Times

FILE PHOTO: Vials with a sticker reading "Covid-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
World+Biz

Moderna sues Pfizer/BioNTech for patent infringement over Covid vaccine

File Photo: A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration
Coronavirus chronicle

Variant-adapted Covid vaccine wins first approval in Britain

US FDA advisers weigh Moderna Covid vaccine heart risk for young men
Coronavirus chronicle

US FDA advisers weigh Moderna Covid vaccine heart risk for young men

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo
Coronavirus chronicle

US health authority says Moderna vaccine effective in under-fives

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Japan study shows women more likely to get skin rash from Moderna shot

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna raises full-year Covid vaccine sales forecast to $21 billion

Moderna has recently signed vaccine orders for 2022 worth $17 billion — which would make it one of the best-selling drugs in the world. Photo: Reuters
Coronavirus chronicle

Moderna to seek regulatory approval for Covid shot for very young children

Coronavirus: On 16 November, 2020, US biotech company Moderna announced a vaccine against Covid-19 that is 94.5% effective. Montreal, 16 November, 2020/ Reuters
Global Economy

Covid vaccine maker Moderna flags Japan ambition with sumo sponsorship